Optimized Lipid Nanoparticles for Co‐Delivery of mRNA and siRNA Therapeutics in Refractory Liver Cancer

Journal:
Advanced Materials
Published:
DOI:
10.1002/adma.202519473
Affiliations:
6
Authors:
10
Go to article
Institutions Authors Share
State Key Laboratory of Drug Research (SKLDR), SIMM CAS, China
2.833333
 0.28
Bohai Rim Advanced Research Institute for Drug Discovery, China
2.833333
 0.28
Zhongnan Hospital, WHU, China
2.666667
 0.27
Wuhan University (WHU), China
0.750000
 0.08
National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, China
0.583333
 0.06
Shandong Second Medical University, China
0.333333
 0.03
Interested in Oncology and Carcinogenesis?